Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Blood
|
July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
David A Sallman, Amy F McLemore, Amy L Aldrich, et al.
Blood Advances
|
February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma
William A Wood, Shaji K Kumar, Emily Semmel, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Blood
|
December 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma
Sanjal H Desai, Alison J Moskowitz, Reid W Merryman, et al.
Blood Advances
|
March 27, 2026
Impact of Novel Therapies on the Efficacy of Post-Transplantation Brentuximab Vedotin Maintenance in Hodgkin Lymphoma
Ayo Samuel Falade, Robert Redd, Sanjal H Desai, et al.
Blood Advances
|
July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
The New England Journal of Medicine
|
September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Jennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood
|
May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
Rainer Claus, David M Lucas, Amy S Ruppert, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Blood
|
July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
David A Sallman, Amy F McLemore, Amy L Aldrich, et al.
Blood Advances
|
February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma
William A Wood, Shaji K Kumar, Emily Semmel, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Blood
|
December 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma
Sanjal H Desai, Alison J Moskowitz, Reid W Merryman, et al.
Blood Advances
|
March 27, 2026
Impact of Novel Therapies on the Efficacy of Post-Transplantation Brentuximab Vedotin Maintenance in Hodgkin Lymphoma
Ayo Samuel Falade, Robert Redd, Sanjal H Desai, et al.
Blood Advances
|
July 26, 2023
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, et al.
The New England Journal of Medicine
|
September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Jennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood
|
May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
Rainer Claus, David M Lucas, Amy S Ruppert, et al.
Page
of 12